Champions Oncology, Inc. (CSBR)

Champions Oncology Market Cap

Champions Oncology has a market cap or net worth of $79.85 million as of April 10, 2026. Its market cap has decreased by -39.65% in one year.

• Market Cap: 79.85M
• Enterprise Value: 77.72M
• 1-Year Change: -39.65%
• Ranking: #4319
• Category: Micro-Cap
• Stock Price: $5.75

Market Cap Chart

Since February 2, 2007, Champions Oncology's market cap has increased from $10.70M to $79.85M, an increase of 646.25%. That is a compound annual growth rate of 11.04%.

Market Cap History

Date	Market Cap	% Change
Apr 10, 2026	79.80M	-16.88%
Dec 31, 2025	96.00M	-18.92%
Dec 31, 2024	118.40M	54.97%
Dec 29, 2023	76.40M	25.04%
Dec 30, 2022	61.10M	-45.93%
Dec 31, 2021	113.00M	-21.69%
Dec 31, 2020	144.30M	49.07%
Dec 31, 2019	96.80M	8.04%
Dec 31, 2018	89.60M	110.33%
Dec 29, 2017	42.60M	53.79%
Dec 30, 2016	27.70M	-10.93%
Dec 31, 2015	31.10M	-6.89%
Dec 31, 2014	33.40M	-58.35%
Dec 31, 2013	80.20M	468.79%
Dec 31, 2012	14.10M	-59.94%
Dec 30, 2011	35.20M	6.02%
Dec 31, 2010	33.20M	26.24%
Dec 31, 2009	26.30M	-26.74%
Dec 31, 2008	35.90M	-19.14%
Dec 31, 2007	44.40M	314.95%
Feb 2, 2007	10.70M	-

View and export this data all the way back to 2007. Sign Up Today.

Related Stocks

Company	Market Cap
PolyPid	82.25M
aTyr Pharma	81.62M
Cognition Therapeutics	80.83M
Seres Therapeutics	79.76M
Pliant Therapeutics	79.25M
OKYO Pharma	79.24M
Filana Therapeutics	79.22M
Estrella Immunopharma	78.50M